Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07262944

EOI Block in Otoplasty With Rib Cartilage Graft

Effect of Ultrasound-Guided External Oblique Intercostal Fascial Plane Block in Pediatric Patients Undergoing Otoplasty With Rib Cartilage Graft

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
13 Years – 18 Years
Healthy volunteers
Not accepted

Summary

This randomized controlled trial aims to evaluate the effect of ultrasound-guided external oblique intercostal (EOI) fascial plane block on postoperative pain control and recovery in pediatric patients undergoing otoplasty with rib cartilage graft under general anesthesia. Participants aged 13 to 18 years will be randomly assigned to receive either EOI block with 0.2% ropivacaine or no block. Primary outcome is total opioid consumption within 24 hours after surgery. Secondary outcomes include NRS pain scores, incentive spirometry performance, incidence of atelectasis, and patient satisfaction.

Conditions

Interventions

TypeNameDescription
PROCEDUREUltrasound-guided External Oblique Intercostal (EOI) Fascial Plane BlockUnder general anesthesia, a linear ultrasound probe (6-13 MHz) is placed transversely at the 8th-9th intercostal space along the anterior axillary line. A 22-gauge, 50-80 mm needle is advanced in-plane into the fascial plane between the external oblique and intercostal muscles. After confirming correct needle placement, 0.2% ropivacaine 0.5 mL/kg (maximum 30 mL) is injected. The procedure is performed at the end of otoplasty with rib cartilage graft to provide postoperative analgesia.
PROCEDUREStandard postoperative pain management (no EOI block)Participants will not receive the EOI block. All other perioperative management, including general anesthesia and postoperative intravenous patient-controlled analgesia (IV-PCA) with fentanyl, will be identical to the experimental group.

Timeline

Start date
2026-12-01
Primary completion
2028-06-01
Completion
2028-08-30
First posted
2025-12-04
Last updated
2025-12-04

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT07262944. Inclusion in this directory is not an endorsement.